首页 > 最新文献

Medical archives (Sarajevo, Bosnia and Herzegovina)最新文献

英文 中文
Prevalence of Pulmonary Embolism in COVID-19 at Quaternary Hospital Running Head: Pulmonary Embolism in COVID-19. 第四医院 COVID-19 中肺栓塞的发病率 跑题:COVID-19 中的肺栓塞。
Pub Date : 2024-01-01 DOI: 10.5455/medarh.2024.78.146-148
Jose Maria Pereira de Godoy, Aline Giovana Dizero, Marcia Valeria Caldeira Angelucci Lopes

Background: Patients with COVID-19 are at greater risk of pulmonary embolism.

Objective: The aim of the present study was to evaluate the monthly prevalence of pulmonary embolism diagnosed by angiotomography and mortality between March 2020 and May 2021 in more than 6000 patients hospitalized with COVID-19 at a single institution.

Methods: A clinical trial was conducted with evaluated medical records the patients hospitalized at the institution who developed pulmonary embolism determined by angiotomography. Monthly and overall mortality rates between March 2020 and May 2021 in this population were evaluated.

Results: A total of 6040 patients were hospitalized in this period, 203 of whom (3.36%) had an angiotomographic diagnosis of pulmonary embolism and 119 of these patients (58.62%) died. The largest number of patients with pulmonary embolism occurred in the periods from July to September 2020 and March to May 2021. No significant difference was found between mortality and the two peaks of the pandemic (p = 0.9, Fisher's exact test).

Conclusion: Pulmonary embolism is associated a higher mortality rate among patients with COVID-19. Therefore, one of the strategies is an emphasis on the prevention of thrombotic and embolic events.

背景:COVID-19 患者肺栓塞风险更高:COVID-19患者发生肺栓塞的风险更高:本研究旨在评估 2020 年 3 月至 2021 年 5 月期间,在一家医疗机构住院的 6000 多名 COVID-19 患者中,每月通过血管造影术确诊的肺栓塞发病率和死亡率:通过血管造影术确诊肺栓塞的住院患者的病历进行临床试验。结果:共有 6040 名患者在该机构住院治疗:在此期间,共有 6040 名患者住院治疗,其中 203 人(3.36%)经血管造影诊断为肺栓塞,119 人(58.62%)死亡。在 2020 年 7 月至 9 月和 2021 年 3 月至 5 月期间,肺栓塞患者人数最多。死亡率与大流行的两个高峰期之间没有明显差异(P = 0.9,费雪精确检验):肺栓塞与 COVID-19 患者的高死亡率有关。因此,预防血栓和栓塞事件是重点策略之一。
{"title":"Prevalence of Pulmonary Embolism in COVID-19 at Quaternary Hospital Running Head: Pulmonary Embolism in COVID-19.","authors":"Jose Maria Pereira de Godoy, Aline Giovana Dizero, Marcia Valeria Caldeira Angelucci Lopes","doi":"10.5455/medarh.2024.78.146-148","DOIUrl":"10.5455/medarh.2024.78.146-148","url":null,"abstract":"<p><strong>Background: </strong>Patients with COVID-19 are at greater risk of pulmonary embolism.</p><p><strong>Objective: </strong>The aim of the present study was to evaluate the monthly prevalence of pulmonary embolism diagnosed by angiotomography and mortality between March 2020 and May 2021 in more than 6000 patients hospitalized with COVID-19 at a single institution.</p><p><strong>Methods: </strong>A clinical trial was conducted with evaluated medical records the patients hospitalized at the institution who developed pulmonary embolism determined by angiotomography. Monthly and overall mortality rates between March 2020 and May 2021 in this population were evaluated.</p><p><strong>Results: </strong>A total of 6040 patients were hospitalized in this period, 203 of whom (3.36%) had an angiotomographic diagnosis of pulmonary embolism and 119 of these patients (58.62%) died. The largest number of patients with pulmonary embolism occurred in the periods from July to September 2020 and March to May 2021. No significant difference was found between mortality and the two peaks of the pandemic (p = 0.9, Fisher's exact test).</p><p><strong>Conclusion: </strong>Pulmonary embolism is associated a higher mortality rate among patients with COVID-19. Therefore, one of the strategies is an emphasis on the prevention of thrombotic and embolic events.</p>","PeriodicalId":94135,"journal":{"name":"Medical archives (Sarajevo, Bosnia and Herzegovina)","volume":"78 2","pages":"146-148"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10983093/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140874020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Novel TSHR Gene Mutation in a Family with Non-autoimmune Hyperthyroidism. 一个非自身免疫性甲状腺功能亢进症家族的新型 TSHR 基因突变
Pub Date : 2024-01-01 DOI: 10.5455/medarh.2024.78.154-158
Tamara Kufoof, Catherine Luxford, Kishani Kannangara, Roderick Clifton-Bligh, Kim C Donaghue

Background: Familial non-autoimmune hyperthyroidism is a rare disorder characterized by the absence of thyroid autoimmunity, particularly TSH receptor antibody [TRAb].

Objective: The aim of this study was to describe a novel TSHR mutation identified in a family of two siblings and their father.

Methods: Two siblings presented for endocrine assessment at ages 7 and 14 years with mild T3 toxicosis, and the father presented at 30 years of age with non-autoimmune thyrotoxicosis. Both siblings were treated with oral antithyroid therapy to achieve reasonable symptom control and thyroid function normalization. The father was treated with oral antithyroid therapy, radioactive iodine, thyroidectomy, and thyroid replacement therapy. Peripheral blood DNA was extracted from both affected siblings and father. Mutation analysis of TSHR was carried out by PCR and Sanger sequencing of both strands of the extracted DNA.

Results: Both siblings and their father were heterozygous for the missense TSHR variant c.1855G>C, p.[Asp619His], in exon 10.

Conclusions: This novel TSHR variant is associated with T3 toxicosis during childhood. Therefore, early identification and treatment may improve patient outcomes.

背景:家族性非自身免疫性甲状腺功能亢进症是一种罕见疾病,其特点是缺乏甲状腺自身免疫,尤其是TSH受体抗体[TRAb]:本研究旨在描述在一个由两兄妹及其父亲组成的家庭中发现的一种新型 TSHR 突变:两兄妹分别在7岁和14岁时因轻度T3中毒症接受内分泌评估,父亲在30岁时出现非自身免疫性甲状腺中毒症。两兄妹均接受了口服抗甲状腺治疗,症状得到了合理控制,甲状腺功能恢复正常。父亲接受了口服抗甲状腺治疗、放射性碘治疗、甲状腺切除术和甲状腺替代疗法。从患者兄弟姐妹和父亲身上提取了外周血DNA。通过聚合酶链反应(PCR)和对提取的DNA双链进行桑格测序,对TSHR进行了突变分析:结果:两兄妹及其父亲均为外显子 10 中 c.1855G>C,p.[Asp619His]错义 TSHR 变异的杂合子:这种新型 TSHR 变异与儿童期 T3 中毒有关。因此,早期识别和治疗可改善患者的预后。
{"title":"A Novel TSHR Gene Mutation in a Family with Non-autoimmune Hyperthyroidism.","authors":"Tamara Kufoof, Catherine Luxford, Kishani Kannangara, Roderick Clifton-Bligh, Kim C Donaghue","doi":"10.5455/medarh.2024.78.154-158","DOIUrl":"https://doi.org/10.5455/medarh.2024.78.154-158","url":null,"abstract":"<p><strong>Background: </strong>Familial non-autoimmune hyperthyroidism is a rare disorder characterized by the absence of thyroid autoimmunity, particularly TSH receptor antibody [TRAb].</p><p><strong>Objective: </strong>The aim of this study was to describe a novel TSHR mutation identified in a family of two siblings and their father.</p><p><strong>Methods: </strong>Two siblings presented for endocrine assessment at ages 7 and 14 years with mild T3 toxicosis, and the father presented at 30 years of age with non-autoimmune thyrotoxicosis. Both siblings were treated with oral antithyroid therapy to achieve reasonable symptom control and thyroid function normalization. The father was treated with oral antithyroid therapy, radioactive iodine, thyroidectomy, and thyroid replacement therapy. Peripheral blood DNA was extracted from both affected siblings and father. Mutation analysis of TSHR was carried out by PCR and Sanger sequencing of both strands of the extracted DNA.</p><p><strong>Results: </strong>Both siblings and their father were heterozygous for the missense TSHR variant c.1855G>C, p.[Asp619His], in exon 10.</p><p><strong>Conclusions: </strong>This novel TSHR variant is associated with T3 toxicosis during childhood. Therefore, early identification and treatment may improve patient outcomes.</p>","PeriodicalId":94135,"journal":{"name":"Medical archives (Sarajevo, Bosnia and Herzegovina)","volume":"78 2","pages":"154-158"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10983094/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140869834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sporadic Malignant Triton Tumor of Shoulder: a Case Report. 肩部散发性恶性天疱疮:病例报告。
Pub Date : 2024-01-01 DOI: 10.5455/medarh.2024.78.174-176
Mohammad Al-Alwan, Ghaith Abu Noar, Ayat Al-Alwan, Sura Alrwabdeh, Mahmood Etawi

Background: Malignant triton tumors (MTT) are subtype of malignant peripheral nerve sheath tumor (MPNST) which develop from Schwan cells of peripheral nerves or within neurofibromas, and shows rhabdomyoblastic differentiation. It is a rare soft tissue tumor with poor prognosis.

Objective: We report a case of Malignant Triton Tumor (MTT) arising in the right shoulder in a 46 year old male patient presented to our Musculoskeletal Oncology Clinic at Royal Rehabilitation center at King Hussein Medical Center during June 2018.

Case presentation: The patient was complaining of an 8 months long progressive right shoulder pain and swelling at the posterior lateral area of the shoulder. As accurate diagnosis is crucial in such case, investigations that included x-rays and magnetic resonance imaging (MRI) demonstrated an soft tissue tumor involving the right shoulder area leading to the differential diagnosis of aggressive soft tissue tumor which laid down the plan of an open incisional biopsy to be reported histopathological as a case of Malignant Triton Tumor which is a very rare and aggressive sarcoma originates from the peripheral nerve sheaths as it is subtype of malignant peripheral nerve sheath tumors after which excision of the entire tumor with safety margin was performed and referred for adjuvant chemotherapy.

Conclusion: The treatment of choice is radical tumor excision with wide margins followed by chemotherapy and /or radiotherapy to improve the 5 years survival rates.

背景:恶性三联瘤(MTT)是恶性周围神经鞘瘤(MPNST)的一种亚型,由周围神经的施万细胞或神经纤维瘤内的施万细胞发展而来,呈横纹肌母细胞分化。它是一种罕见的软组织肿瘤,预后较差:我们报告了一例于 2018 年 6 月在侯赛因国王医疗中心皇家康复中心肌肉骨骼肿瘤门诊就诊的 46 岁男性患者右肩发生的恶性天疱疮(MTT)病例:患者主诉长达 8 个月的进行性右肩疼痛和肩部后外侧区域肿胀。在这种情况下,准确诊断至关重要、检查包括 XX射线和磁共振成像(MRI)检查显示,患者右肩部位患有软组织肿瘤,因此鉴别诊断为侵袭性软组织肿瘤,并制定了开放切口活检计划,组织病理学报告为恶性Triton肿瘤,这是一种非常罕见的侵袭性肉瘤,起源于周围神经鞘,是恶性周围神经鞘瘤的一种亚型。结论首选的治疗方法是根治性肿瘤切除术,并留有较宽的切缘,然后进行化疗和/或放疗,以提高患者的 5 年生存率。
{"title":"Sporadic Malignant Triton Tumor of Shoulder: a Case Report.","authors":"Mohammad Al-Alwan, Ghaith Abu Noar, Ayat Al-Alwan, Sura Alrwabdeh, Mahmood Etawi","doi":"10.5455/medarh.2024.78.174-176","DOIUrl":"https://doi.org/10.5455/medarh.2024.78.174-176","url":null,"abstract":"<p><strong>Background: </strong>Malignant triton tumors (MTT) are subtype of malignant peripheral nerve sheath tumor (MPNST) which develop from Schwan cells of peripheral nerves or within neurofibromas, and shows rhabdomyoblastic differentiation. It is a rare soft tissue tumor with poor prognosis.</p><p><strong>Objective: </strong>We report a case of Malignant Triton Tumor (MTT) arising in the right shoulder in a 46 year old male patient presented to our Musculoskeletal Oncology Clinic at Royal Rehabilitation center at King Hussein Medical Center during June 2018.</p><p><strong>Case presentation: </strong>The patient was complaining of an 8 months long progressive right shoulder pain and swelling at the posterior lateral area of the shoulder. As accurate diagnosis is crucial in such case, investigations that included x-rays and magnetic resonance imaging (MRI) demonstrated an soft tissue tumor involving the right shoulder area leading to the differential diagnosis of aggressive soft tissue tumor which laid down the plan of an open incisional biopsy to be reported histopathological as a case of Malignant Triton Tumor which is a very rare and aggressive sarcoma originates from the peripheral nerve sheaths as it is subtype of malignant peripheral nerve sheath tumors after which excision of the entire tumor with safety margin was performed and referred for adjuvant chemotherapy.</p><p><strong>Conclusion: </strong>The treatment of choice is radical tumor excision with wide margins followed by chemotherapy and /or radiotherapy to improve the 5 years survival rates.</p>","PeriodicalId":94135,"journal":{"name":"Medical archives (Sarajevo, Bosnia and Herzegovina)","volume":"78 2","pages":"174-176"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10983085/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140859452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Juvenile Papillomatosis of the Breast: a Report of Two Cases with Review of the literature. 乳腺幼年乳头状瘤病:两例病例报告及文献综述。
Pub Date : 2024-01-01 DOI: 10.5455/medarh.2024.78.170-173
Mariam Al-Qurashi, Arwa Ibrahim, Tarek M ElSharkawy, Areej Al Nemer, Hiyam Alhaddad, Maha Abdel Hadi

Background: Juvenile papillomatosis (JP) of the breast is a rare and benign proliferative disorder affecting young women. The affected patients tend to have an increased risk of breast cancer development during follow-up.

Objective: This article aims to highlight a rare entity of breast disease, that harbor risk of breast cancer.

Case presentation: Here, we present 2 cases of JP in young females; the first case is a 13 year-old presented with spontaneous nipple discharge, while the other patient is a 24 year-old presented with a right breast lump. Both patients had a total excision of the breast lesions, revealing JP at histology. Discussion: Juvenile Papillomatosis is considered a clinicopathological entity and is usually misdiagnosed as fibroadenoma clinically and radiologically, which requires histological correlation. The histologic findings are well-defined (hyperplasia, papillomatosis, and multiple cysts with foamy histiocytes).The controversy in management between surgery and observation is because of insufficient knowledge about the direct relationship between JP and subsequent cancer.

Conclusion: Considering the risk of developing breast cancer in JP, enrolling patients and their families in a close follow-up and surveillance program is crucial.

背景:乳腺幼年乳头状瘤病(JP)是一种影响年轻女性的罕见良性增生性疾病。受影响的患者在随访期间发生乳腺癌的风险往往会增加:本文旨在强调一种罕见的乳腺疾病,这种疾病有诱发乳腺癌的风险:本文介绍了两例年轻女性的 JP 病例:第一例患者 13 岁,自发乳头溢液;第二例患者 24 岁,右侧乳房肿块。两名患者均接受了乳腺病灶全切术,组织学检查均显示为 JP。讨论幼年乳头状瘤病被认为是一种临床病理实体,通常在临床和影像学上被误诊为纤维腺瘤,这需要组织学相关性。组织学检查结果定义明确(增生、乳头状瘤病和多发性囊肿伴泡沫状组织细胞)。在手术治疗和观察治疗之间存在争议的原因是对 JP 与后续癌症之间的直接关系认识不足:考虑到JP患者罹患乳腺癌的风险,将患者及其家属纳入密切随访和监测计划至关重要。
{"title":"Juvenile Papillomatosis of the Breast: a Report of Two Cases with Review of the literature.","authors":"Mariam Al-Qurashi, Arwa Ibrahim, Tarek M ElSharkawy, Areej Al Nemer, Hiyam Alhaddad, Maha Abdel Hadi","doi":"10.5455/medarh.2024.78.170-173","DOIUrl":"https://doi.org/10.5455/medarh.2024.78.170-173","url":null,"abstract":"<p><strong>Background: </strong>Juvenile papillomatosis (JP) of the breast is a rare and benign proliferative disorder affecting young women. The affected patients tend to have an increased risk of breast cancer development during follow-up.</p><p><strong>Objective: </strong>This article aims to highlight a rare entity of breast disease, that harbor risk of breast cancer.</p><p><strong>Case presentation: </strong>Here, we present 2 cases of JP in young females; the first case is a 13 year-old presented with spontaneous nipple discharge, while the other patient is a 24 year-old presented with a right breast lump. Both patients had a total excision of the breast lesions, revealing JP at histology. Discussion: Juvenile Papillomatosis is considered a clinicopathological entity and is usually misdiagnosed as fibroadenoma clinically and radiologically, which requires histological correlation. The histologic findings are well-defined (hyperplasia, papillomatosis, and multiple cysts with foamy histiocytes).The controversy in management between surgery and observation is because of insufficient knowledge about the direct relationship between JP and subsequent cancer.</p><p><strong>Conclusion: </strong>Considering the risk of developing breast cancer in JP, enrolling patients and their families in a close follow-up and surveillance program is crucial.</p>","PeriodicalId":94135,"journal":{"name":"Medical archives (Sarajevo, Bosnia and Herzegovina)","volume":"78 2","pages":"170-173"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10983086/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140873801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chordoma of the Oropharynx. 口咽脊索瘤
Pub Date : 2024-01-01 DOI: 10.5455/medarh.2024.78.68-70
Almedina Ramas, Merima Kasumovic, Sabrina Uscupsic, Majda Mujic, Lejla Tokic

Background: Chordoma is a rare malignant neoplasm that predominantly arises from the axial skeleton, but can also develop in unusual locations. However, there are also rare cases of "NOS" chordoma involving the oropharyx and epithelial-myoepithelial carcinoma of the parotid gland in the same patient. According to contemporary research, chordoma is a rare malignant neoplasm that arises from the embryonic remnants of the notochord. and typically involves the clivus, sacrococcygeal bones or vertebrae. Studies have shown that the incidence of chordoma has been estimated to be one per one million people per year. Chordoma can occur at any age, but most commonly it is diagnosed in the 40-60 year old age group with the male predominance.

Objective: The aim of this article was to review the case of a 74-year-old female patient with epithelial-myoepithelial carcinoma of the parotid gland and a case of "NOS" chordoma involving the oropharyx.

Methods: Diagnostic methods were used to examine a female patient with two primary malignant tumors: CT neck scan, CT of paranasal sinuses, ultrasound examination, scintigraphy and operative finding.

Case presentzation: Due to the anatomy complexity, complete resection of the tumor through a transoral-transpharyngeal approach was not possible. Intraoperative palpation of the mass revealed well defined submucosal lesion 20x43x46mm beginning at the level of the oro- and hypopharynx and extending superiorly to the nasopharynx, and posteriorly into the spinal canal and intervertebral foramen causing near complete occlusion of the oro and hypopharynx. The patient also underwent extracapsular dissection of the parotid tumor. Postoperative palliative radiotherapy was performed.

Conclusion: Surgical treatment remains the mainstay of treatment for EMC and radiation is imperative for patients who refuse surgery and for those with advanced or inoperable diseases.

背景:脊索瘤是一种罕见的恶性肿瘤,主要发生于轴状骨骼,但也可能发生在不寻常的部位。然而,也有罕见病例显示,同一患者同时患有累及口咽的 "NOS "脊索瘤和腮腺上皮-肌上皮癌。根据当代研究,脊索瘤是一种罕见的恶性肿瘤,起源于胚胎时期的脊索残基,通常累及颅骨、骶尾骨或椎骨。研究表明,脊索瘤的发病率估计为每年百万分之一。脊索瘤可发生于任何年龄,但最常被诊断为脊索瘤的年龄为 40-60 岁,男性居多:本文旨在回顾一例 74 岁女性腮腺上皮-肌上皮癌患者和一例累及口咽的 "NOS "脊索瘤病例:采用诊断方法对一名患有两种原发性恶性肿瘤的女性患者进行了检查:病例介绍:由于解剖结构复杂,无法通过经口-经咽入路完全切除肿瘤。术中对肿块的触诊显示,从口咽和下咽处开始的粘膜下病变清晰可见,大小为 20x43x46mm,向上部延伸至鼻咽部,向后部延伸至椎管和椎间孔,导致口咽和下咽近乎完全闭塞。患者还接受了腮腺肿瘤囊外切除术。术后进行了姑息性放疗:手术治疗仍是治疗 EMC 的主要方法,对于拒绝手术的患者以及晚期或无法手术的患者,放射治疗势在必行。
{"title":"Chordoma of the Oropharynx.","authors":"Almedina Ramas, Merima Kasumovic, Sabrina Uscupsic, Majda Mujic, Lejla Tokic","doi":"10.5455/medarh.2024.78.68-70","DOIUrl":"10.5455/medarh.2024.78.68-70","url":null,"abstract":"<p><strong>Background: </strong>Chordoma is a rare malignant neoplasm that predominantly arises from the axial skeleton, but can also develop in unusual locations. However, there are also rare cases of \"NOS\" chordoma involving the oropharyx and epithelial-myoepithelial carcinoma of the parotid gland in the same patient. According to contemporary research, chordoma is a rare malignant neoplasm that arises from the embryonic remnants of the notochord. and typically involves the clivus, sacrococcygeal bones or vertebrae. Studies have shown that the incidence of chordoma has been estimated to be one per one million people per year. Chordoma can occur at any age, but most commonly it is diagnosed in the 40-60 year old age group with the male predominance.</p><p><strong>Objective: </strong>The aim of this article was to review the case of a 74-year-old female patient with epithelial-myoepithelial carcinoma of the parotid gland and a case of \"NOS\" chordoma involving the oropharyx.</p><p><strong>Methods: </strong>Diagnostic methods were used to examine a female patient with two primary malignant tumors: CT neck scan, CT of paranasal sinuses, ultrasound examination, scintigraphy and operative finding.</p><p><strong>Case presentzation: </strong>Due to the anatomy complexity, complete resection of the tumor through a transoral-transpharyngeal approach was not possible. Intraoperative palpation of the mass revealed well defined submucosal lesion 20x43x46mm beginning at the level of the oro- and hypopharynx and extending superiorly to the nasopharynx, and posteriorly into the spinal canal and intervertebral foramen causing near complete occlusion of the oro and hypopharynx. The patient also underwent extracapsular dissection of the parotid tumor. Postoperative palliative radiotherapy was performed.</p><p><strong>Conclusion: </strong>Surgical treatment remains the mainstay of treatment for EMC and radiation is imperative for patients who refuse surgery and for those with advanced or inoperable diseases.</p>","PeriodicalId":94135,"journal":{"name":"Medical archives (Sarajevo, Bosnia and Herzegovina)","volume":"78 1","pages":"68-70"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10928678/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140121650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethical Challenges with the Informed Consent Process in Pediatric Research Studies. 儿科研究中知情同意程序的伦理挑战。
Pub Date : 2024-01-01 DOI: 10.5455/medarh.2024.78.65-67
Thabit S Alotaibi

Background: Informed Consent (IC) is crucial in pediatric research, aligning with the National Research Act of 1974 and the Belmont Report's principles. Current regulations, particularly 45 CFR 46, provide additional safeguards for children in research.

Objective: This article explores ethical challenges in pediatric research IC, drawing from PubMed literature and regulatory guidelines to understand historical context, legislative milestones, and contemporary issues.

Methods: A literature review, primarily sourced from PubMed, informed the examination of pediatric research and IC, referencing guidelines from the American Academy of Pediatrics and regulations from the FDA and HHS.

Results: The study underscores the need for increased pediatric research due to the prevalence of drugs studied on adults. Despite legislative efforts like the FDAMA and Pediatric Research Equity Act, ethical challenges persist in obtaining IC in pediatric studies.

Conclusion: Pediatric research necessitates nuanced IC approaches, involving parents, guardians, and children. Ethical challenges such as coercion and compensation require attention, with recommendations emphasizing guideline adherence and increased public engagement for trust-building and pediatric health advancement.

背景:知情同意(IC)对于儿科研究至关重要,它符合 1974 年《国家研究法》和贝尔蒙特报告的原则。现行法规,尤其是美国联邦法典第 45 卷第 46 条,为研究中的儿童提供了额外的保障:本文探讨了儿科研究 IC 中的伦理挑战,从 PubMed 文献和监管指南中了解历史背景、立法里程碑和当代问题:方法:文献综述主要来自 PubMed,为儿科研究和 IC 的研究提供了信息,同时参考了美国儿科学会的指导方针以及 FDA 和 HHS 的法规:研究强调,由于成人药物研究的普遍性,因此有必要加强儿科研究。尽管美国食品及药物管理局(FDAMA)和《儿科研究公平法案》(Pediatric Research Equity Act)等立法机构做出了努力,但在儿科研究中获得IC的伦理挑战依然存在:结论:儿科研究需要细致入微的IC方法,需要家长、监护人和儿童的参与。需要关注强迫和补偿等伦理挑战,建议强调遵守指南和加强公众参与,以建立信任和促进儿科健康。
{"title":"Ethical Challenges with the Informed Consent Process in Pediatric Research Studies.","authors":"Thabit S Alotaibi","doi":"10.5455/medarh.2024.78.65-67","DOIUrl":"10.5455/medarh.2024.78.65-67","url":null,"abstract":"<p><strong>Background: </strong>Informed Consent (IC) is crucial in pediatric research, aligning with the National Research Act of 1974 and the Belmont Report's principles. Current regulations, particularly 45 CFR 46, provide additional safeguards for children in research.</p><p><strong>Objective: </strong>This article explores ethical challenges in pediatric research IC, drawing from PubMed literature and regulatory guidelines to understand historical context, legislative milestones, and contemporary issues.</p><p><strong>Methods: </strong>A literature review, primarily sourced from PubMed, informed the examination of pediatric research and IC, referencing guidelines from the American Academy of Pediatrics and regulations from the FDA and HHS.</p><p><strong>Results: </strong>The study underscores the need for increased pediatric research due to the prevalence of drugs studied on adults. Despite legislative efforts like the FDAMA and Pediatric Research Equity Act, ethical challenges persist in obtaining IC in pediatric studies.</p><p><strong>Conclusion: </strong>Pediatric research necessitates nuanced IC approaches, involving parents, guardians, and children. Ethical challenges such as coercion and compensation require attention, with recommendations emphasizing guideline adherence and increased public engagement for trust-building and pediatric health advancement.</p>","PeriodicalId":94135,"journal":{"name":"Medical archives (Sarajevo, Bosnia and Herzegovina)","volume":"78 1","pages":"65-67"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10928675/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140121652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serotonin Levels in Newly-Infected HIV-Positive: A Preliminary Study. 新感染艾滋病毒阳性者的血清素水平:初步研究。
Pub Date : 2024-01-01 DOI: 10.5455/medarh.2024.78.55-59
Muh Yusuf Tahir, Andi Agus Mumang, Kusrini S Kadar, Risna Halim Mubin, Firdaus Hamid

Background: HIV is still a global health concern worldwide and in 2021, a total of 27,000 newly infected cases were detected in the Indonesian population, specifically among adults. However, there is no available data found about serotonin levels in newly infected cases of HIV.

Objective: This study aimed to preliminary investigate serotonin levels in newly-infected HIV-positive cases in the Indonesian population.

Methods: A quantitative cross-sectional analytic design was used with a total of 54 newly-infected HIV-positive participants who were enrolled using the purposive sampling technique. The questionnaire, blood sampling, and ELISA methods for measuring serotonin were applied. Furthermore, the serotonin distribution was compared based on participants' characteristics using the Mann-Whitney U test. The main effect of characteristics was also tested by the generalized linear model.

Results: The mean serotonin level was low and did not differ based on participants' characteristics.

Conclusion: Low serotonin level is characteristic of people newly infected with HIV in Indonesia. This might be a manifestation of the depression stage, a consequence of infection, or the involvement in provoking HIV infection progression.

背景:2021 年,印度尼西亚人口中发现了 27,000 例新感染病例,尤其是在成年人中。然而,目前还没有关于新感染艾滋病毒病例中血清素水平的数据:本研究旨在初步调查印尼人群中新感染 HIV 阳性病例的血清素水平:方法:采用定量横断面分析设计,使用目的性抽样技术共招募了 54 名新感染的 HIV 阳性参与者。采用问卷调查法、血液采样法和酶联免疫吸附法测量血清素。此外,还使用曼-惠特尼 U 检验比较了血清素分布的参与者特征。结果显示,血清素的平均水平较低:结果:血清素的平均水平较低,且不因参与者的特征而异:结论:血清素水平低是印度尼西亚新感染艾滋病毒者的特征。这可能是抑郁阶段的一种表现,也可能是感染的一种后果,或者是导致艾滋病病毒感染进展的因素之一。
{"title":"Serotonin Levels in Newly-Infected HIV-Positive: A Preliminary Study.","authors":"Muh Yusuf Tahir, Andi Agus Mumang, Kusrini S Kadar, Risna Halim Mubin, Firdaus Hamid","doi":"10.5455/medarh.2024.78.55-59","DOIUrl":"10.5455/medarh.2024.78.55-59","url":null,"abstract":"<p><strong>Background: </strong>HIV is still a global health concern worldwide and in 2021, a total of 27,000 newly infected cases were detected in the Indonesian population, specifically among adults. However, there is no available data found about serotonin levels in newly infected cases of HIV.</p><p><strong>Objective: </strong>This study aimed to preliminary investigate serotonin levels in newly-infected HIV-positive cases in the Indonesian population.</p><p><strong>Methods: </strong>A quantitative cross-sectional analytic design was used with a total of 54 newly-infected HIV-positive participants who were enrolled using the purposive sampling technique. The questionnaire, blood sampling, and ELISA methods for measuring serotonin were applied. Furthermore, the serotonin distribution was compared based on participants' characteristics using the Mann-Whitney U test. The main effect of characteristics was also tested by the generalized linear model.</p><p><strong>Results: </strong>The mean serotonin level was low and did not differ based on participants' characteristics.</p><p><strong>Conclusion: </strong>Low serotonin level is characteristic of people newly infected with HIV in Indonesia. This might be a manifestation of the depression stage, a consequence of infection, or the involvement in provoking HIV infection progression.</p>","PeriodicalId":94135,"journal":{"name":"Medical archives (Sarajevo, Bosnia and Herzegovina)","volume":"78 1","pages":"55-59"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10928688/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140121806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Community-Based Cross-Sectional Assessment Survey On Herpes Zoster Vaccination Practices. 带状疱疹疫苗接种方法社区横断面评估调查。
Pub Date : 2024-01-01 DOI: 10.5455/medarh.2024.78.95-99
Nouf F Bin Rubaian, Nada Alghamdi, Nada Alquorain, Serene R Almuhaidib, Nouf A AlShamlan, Assim M AlAbdulKader, Moataza M Abdel Wahab, Malak A Al-Shammari

Background: Herpes Zoster (HZ), also known as Shingles, is a commonly occurring infection especially among the elderly. It is due to the reactivation of the dormant virus in the sensory ends that were present since the primary infection with the virus.

Objective: Our study aims at assessing the knowledge, attitudes practices beliefs and current barriers towards the Shingrix vaccine to fully understand where we stand and come up with proper recommendations to services these at-risk individuals and ultimately have a positive impact on the healthcare system.

Methods: Questionnaire based cross sectional study using a translated version of a previously developed and tested questionnaire.

Results: more than 8000 participants responded to the survey. The vast majority had chicken pox before and did hear about the vaccine from different sources. Most of the participants had minimal knowledge regarding the vaccine and were willing to take it regardless of some safety concerns.

Conclusion: more efforts need to be conducted to enhance vaccine uptake in at risk populations in Saudi Arabia.

背景:带状疱疹(HZ)又称带状疱疹,是一种常见的感染,尤其是在老年人中。它是由于原发感染病毒后,休眠病毒在感官末端重新激活所致:我们的研究旨在评估有关 Shingrix 疫苗的知识、态度、信仰和当前障碍,以充分了解我们的立场,并提出适当的建议,为这些高危人群提供服务,最终对医疗保健系统产生积极影响:结果:8000 多名参与者参与了调查。绝大多数人以前出过水痘,并从不同渠道听说过疫苗。大多数参与者对疫苗了解甚少,并且愿意接种疫苗,而不考虑一些安全问题。结论:需要做出更多努力来提高沙特阿拉伯高危人群的疫苗接种率。
{"title":"Community-Based Cross-Sectional Assessment Survey On Herpes Zoster Vaccination Practices.","authors":"Nouf F Bin Rubaian, Nada Alghamdi, Nada Alquorain, Serene R Almuhaidib, Nouf A AlShamlan, Assim M AlAbdulKader, Moataza M Abdel Wahab, Malak A Al-Shammari","doi":"10.5455/medarh.2024.78.95-99","DOIUrl":"https://doi.org/10.5455/medarh.2024.78.95-99","url":null,"abstract":"<p><strong>Background: </strong>Herpes Zoster (HZ), also known as Shingles, is a commonly occurring infection especially among the elderly. It is due to the reactivation of the dormant virus in the sensory ends that were present since the primary infection with the virus.</p><p><strong>Objective: </strong>Our study aims at assessing the knowledge, attitudes practices beliefs and current barriers towards the Shingrix vaccine to fully understand where we stand and come up with proper recommendations to services these at-risk individuals and ultimately have a positive impact on the healthcare system.</p><p><strong>Methods: </strong>Questionnaire based cross sectional study using a translated version of a previously developed and tested questionnaire.</p><p><strong>Results: </strong>more than 8000 participants responded to the survey. The vast majority had chicken pox before and did hear about the vaccine from different sources. Most of the participants had minimal knowledge regarding the vaccine and were willing to take it regardless of some safety concerns.</p><p><strong>Conclusion: </strong>more efforts need to be conducted to enhance vaccine uptake in at risk populations in Saudi Arabia.</p>","PeriodicalId":94135,"journal":{"name":"Medical archives (Sarajevo, Bosnia and Herzegovina)","volume":"78 2","pages":"95-99"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10983100/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140862776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of Dark Chocolate and Carrot Juice on Perceived Labor Pain During Stage 1 of Birth Delivery Among Primigravida: A Quasi-Experimental Study. 黑巧克力和胡萝卜汁对初产妇第一产程分娩疼痛感的影响:准实验研究
Pub Date : 2024-01-01 DOI: 10.5455/medarh.2024.78.149-153
Fazdria Fazdria, Alchalidi Alchalidi, Abdurrahman Abdurrahman, Nora Veri, Lina Lina, Cut Mutiah, Yohanes Andy Rias

Background: Dark chocolate and carrot juice may positively decline the pain. However, there is a lack evidence the impact of combination dark chocolate and carrot juice on labor pain during stage 1 of birth delivery among primigravida.

Objective: This study aimed to examine the effectiveness of dark chocolate and carrot juice on perceived labor pain during stage 1 of birth delivery among primigravida.

Methods: This was a quasi-experimental study with participants who received dark chocolate (n=30), carrot juice (n=30), and control group (n=30). Pain level was assessed by using the Numeric Pain Rating Scale (NPRS) before the intervention and at 30 hours after intervention. The Chi-square and one-way analysis of variance tests and general equational model were used.

Results: Data were collected and analyzed before and after 60 minutes of intervention. Our results showed a significant interaction between the group and time, with both groups independently ameliorating labor pain.

Conclusion: Dark chocolate and carrot juice therapies independently lowered pain labor in primigravida mothers, making them a viable treatment for advanced pain labor.

背景:黑巧克力和胡萝卜汁可积极缓解疼痛。然而,目前还没有证据表明黑巧克力和胡萝卜汁对初产妇分娩第一产程疼痛的影响:本研究旨在探讨黑巧克力和胡萝卜汁对初产妇第一产程分娩疼痛的影响:这是一项准实验研究,参与者分别接受了黑巧克力(30 人)、胡萝卜汁(30 人)和对照组(30 人)的治疗。在干预前和干预后 30 小时内,使用数字疼痛评分量表(NPRS)对疼痛程度进行评估。采用了卡方检验、单因素方差分析和一般等式模型:收集并分析了干预前后 60 分钟的数据。结果表明,组别与时间之间存在明显的交互作用,两组都能独立地改善分娩疼痛:结论:黑巧克力和胡萝卜汁疗法可独立减轻初产妇的分娩疼痛,是治疗晚期痛产的可行方法。
{"title":"Effectiveness of Dark Chocolate and Carrot Juice on Perceived Labor Pain During Stage 1 of Birth Delivery Among Primigravida: A Quasi-Experimental Study.","authors":"Fazdria Fazdria, Alchalidi Alchalidi, Abdurrahman Abdurrahman, Nora Veri, Lina Lina, Cut Mutiah, Yohanes Andy Rias","doi":"10.5455/medarh.2024.78.149-153","DOIUrl":"https://doi.org/10.5455/medarh.2024.78.149-153","url":null,"abstract":"<p><strong>Background: </strong>Dark chocolate and carrot juice may positively decline the pain. However, there is a lack evidence the impact of combination dark chocolate and carrot juice on labor pain during stage 1 of birth delivery among primigravida.</p><p><strong>Objective: </strong>This study aimed to examine the effectiveness of dark chocolate and carrot juice on perceived labor pain during stage 1 of birth delivery among primigravida.</p><p><strong>Methods: </strong>This was a quasi-experimental study with participants who received dark chocolate (n=30), carrot juice (n=30), and control group (n=30). Pain level was assessed by using the Numeric Pain Rating Scale (NPRS) before the intervention and at 30 hours after intervention. The Chi-square and one-way analysis of variance tests and general equational model were used.</p><p><strong>Results: </strong>Data were collected and analyzed before and after 60 minutes of intervention. Our results showed a significant interaction between the group and time, with both groups independently ameliorating labor pain.</p><p><strong>Conclusion: </strong>Dark chocolate and carrot juice therapies independently lowered pain labor in primigravida mothers, making them a viable treatment for advanced pain labor.</p>","PeriodicalId":94135,"journal":{"name":"Medical archives (Sarajevo, Bosnia and Herzegovina)","volume":"78 2","pages":"149-153"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10983098/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140862118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling the Anticancer Potential of Pasak Bumi (Eurycoma Longifolia Jack) Root Extract in Prostate Cancer Treatment. 揭示 Pasak Bumi(Eurycoma Longifolia Jack)根提取物在前列腺癌治疗中的抗癌潜力。
Pub Date : 2024-01-01 DOI: 10.5455/medarh.2024.78.117-121
Eka Yudha Rahman, Nia Kania, Hendra Sutapa, Athaya Febriantyo Purnomo, Roselina Panghiyangani, Nika Sterina Skripsiana

Background: Prostate cancer remains a significant global health concern, necessitating the exploration of novel therapeutic avenues to enhance treatment efficacy and mitigate adverse effects. Objective This study delves into the potential anticancer properties of Pasak Bumi (Eurycoma longifolia Jack) root extract, a traditional Southeast Asian medicinal plant, against prostate cancer.

Methods: The research employs a multifaceted approach, encompassing molecular and cellular analyses to unravel the intricate mechanisms underlying Pasak Bumi's effects on prostate cancer cells. Primary focus is given to the PTEN/P13k/Akt pathway, a critical regulator of cell survival and apoptosis. Various concentrations of Pasak Bumi root extract are applied to prostate cancer cell lines, and the impact on apoptosis, cell proliferation, and key molecular targets is assessed.

Results: Preliminary findings reveal that Pasak Bumi root extract induces apoptosis in prostate cancer cells, evidenced by downstream molecular events associated with programmed cell death. The extract demonstrates concentration-dependent effects, with higher concentrations exhibiting more pronounced anticancer activity. Moreover, Pasak Bumi root extract appears to modulate the PTEN/P13k/Akt pathway, providing a potential mechanistic link to its anticancer effects. Discussion: The study's significance lies in its contribution to the evolving landscape of natural compounds as anticancer agents, particularly in the context of prostate cancer. Pasak Bumi's traditional use as a medicinal plant, coupled with emerging scientific evidence, underscores its potential translational value. The observed modulation of the PTEN/P13k/Akt pathway aligns with the current understanding of prostate cancer pathogenesis, offering a plausible explanation for Pasak Bumi's anticancer effects.

Conclusion: This research sheds light on the promising anticancer potential of Pasak Bumi root extract against prostate cancer. Further exploration of its molecular interactions, synergy with conventional therapies, and efficacy at different stages of cancer progression is warranted. The findings present Pasak Bumi as a nature-inspired candidate for prostate cancer treatment, warranting continued investigation into its therapeutic applications. As the scientific community endeavors to enhance cancer treatment modalities, Pasak Bumi emerges as a captivating subject in the pursuit of effective and minimally invasive prostate cancer therapies.

背景:前列腺癌仍然是全球关注的重大健康问题,因此有必要探索新的治疗途径,以提高疗效并减轻不良反应。本研究探讨了东南亚传统药用植物 Pasak Bumi(Eurycoma longifolia Jack)根提取物对前列腺癌的潜在抗癌特性:研究采用多方面的方法,包括分子和细胞分析,以揭示 Pasak Bumi 对前列腺癌细胞产生影响的复杂机制。研究的主要重点是 PTEN/P13k/Akt 通路,它是细胞存活和凋亡的关键调节因子。将不同浓度的 Pasak Bumi 根提取物用于前列腺癌细胞系,评估其对细胞凋亡、细胞增殖和关键分子靶点的影响:初步研究结果表明,Pasak Bumi 根提取物可诱导前列腺癌细胞凋亡,与细胞程序性死亡相关的下游分子事件证明了这一点。萃取物的作用与浓度有关,浓度越高,抗癌活性越明显。此外,Pasak Bumi 根提取物似乎还能调节 PTEN/P13k/Akt 通路,为其抗癌作用提供了潜在的机制联系。讨论:这项研究的意义在于,它为不断发展的天然化合物抗癌剂,尤其是前列腺癌抗癌剂的研究做出了贡献。Pasak Bumi 作为药用植物的传统用途,加上新出现的科学证据,凸显了其潜在的转化价值。观察到的对 PTEN/P13k/Akt 通路的调节与目前对前列腺癌发病机制的理解一致,为 Pasak Bumi 的抗癌作用提供了一个合理的解释:这项研究揭示了 Pasak Bumi 根提取物对前列腺癌的抗癌潜力。有必要对其分子相互作用、与传统疗法的协同作用以及在癌症进展不同阶段的疗效进行进一步探索。研究结果表明,Pasak Bumi 是一种受大自然启发的前列腺癌治疗候选药物,值得继续研究其治疗应用。随着科学界努力改进癌症治疗方法,Pasak Bumi 成为追求有效和微创前列腺癌疗法的一个令人着迷的主题。
{"title":"Unveiling the Anticancer Potential of Pasak Bumi (Eurycoma Longifolia Jack) Root Extract in Prostate Cancer Treatment.","authors":"Eka Yudha Rahman, Nia Kania, Hendra Sutapa, Athaya Febriantyo Purnomo, Roselina Panghiyangani, Nika Sterina Skripsiana","doi":"10.5455/medarh.2024.78.117-121","DOIUrl":"https://doi.org/10.5455/medarh.2024.78.117-121","url":null,"abstract":"<p><strong>Background: </strong>Prostate cancer remains a significant global health concern, necessitating the exploration of novel therapeutic avenues to enhance treatment efficacy and mitigate adverse effects. <b>Objective</b> This study delves into the potential anticancer properties of Pasak Bumi (Eurycoma longifolia Jack) root extract, a traditional Southeast Asian medicinal plant, against prostate cancer.</p><p><strong>Methods: </strong>The research employs a multifaceted approach, encompassing molecular and cellular analyses to unravel the intricate mechanisms underlying Pasak Bumi's effects on prostate cancer cells. Primary focus is given to the PTEN/P13k/Akt pathway, a critical regulator of cell survival and apoptosis. Various concentrations of Pasak Bumi root extract are applied to prostate cancer cell lines, and the impact on apoptosis, cell proliferation, and key molecular targets is assessed.</p><p><strong>Results: </strong>Preliminary findings reveal that Pasak Bumi root extract induces apoptosis in prostate cancer cells, evidenced by downstream molecular events associated with programmed cell death. The extract demonstrates concentration-dependent effects, with higher concentrations exhibiting more pronounced anticancer activity. Moreover, Pasak Bumi root extract appears to modulate the PTEN/P13k/Akt pathway, providing a potential mechanistic link to its anticancer effects. <b>Discussion:</b> The study's significance lies in its contribution to the evolving landscape of natural compounds as anticancer agents, particularly in the context of prostate cancer. Pasak Bumi's traditional use as a medicinal plant, coupled with emerging scientific evidence, underscores its potential translational value. The observed modulation of the PTEN/P13k/Akt pathway aligns with the current understanding of prostate cancer pathogenesis, offering a plausible explanation for Pasak Bumi's anticancer effects.</p><p><strong>Conclusion: </strong>This research sheds light on the promising anticancer potential of Pasak Bumi root extract against prostate cancer. Further exploration of its molecular interactions, synergy with conventional therapies, and efficacy at different stages of cancer progression is warranted. The findings present Pasak Bumi as a nature-inspired candidate for prostate cancer treatment, warranting continued investigation into its therapeutic applications. As the scientific community endeavors to enhance cancer treatment modalities, Pasak Bumi emerges as a captivating subject in the pursuit of effective and minimally invasive prostate cancer therapies.</p>","PeriodicalId":94135,"journal":{"name":"Medical archives (Sarajevo, Bosnia and Herzegovina)","volume":"78 2","pages":"117-121"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10983097/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140862195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medical archives (Sarajevo, Bosnia and Herzegovina)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1